TC-99M DIRECT LABELING OF ANTI-CEA MONOCLONAL-ANTIBODIES - QUALITY-CONTROL AND PRECLINICAL STUDIES

Citation
Sg. Decastiglia et al., TC-99M DIRECT LABELING OF ANTI-CEA MONOCLONAL-ANTIBODIES - QUALITY-CONTROL AND PRECLINICAL STUDIES, Nuclear medicine and biology, 22(3), 1995, pp. 367-372
Citations number
24
Categorie Soggetti
Radiology,Nuclear Medicine & Medical Imaging
Journal title
Nuclear medicine and biology
ISSN journal
09698051 → ACNP
Volume
22
Issue
3
Year of publication
1995
Pages
367 - 372
Database
ISI
SICI code
0969-8051(1995)22:3<367:TDLOAM>2.0.ZU;2-7
Abstract
The anti-carcinoembryonic B2C114 monoclonal antibody was radiolabeled with Tc-99m by a direct method and quality control tested in vitro by instant thin layer chromatography, gel column scanning and cellulose a cetate electrophoresis and assessed in vivo for radioimmunodetection o n a murine spontaneous mammary carcinoma. The optimal results of perce nt Tc-99m bound to protein were obtained at a dithiothreitol:antibody molar ratio ranging from 800:1 to 1000:1 and at a methylene diphosphon ate:stannous fluoride weight ratio of 4.3:1. Although cysteine removed up to 18% of the label during the first 4 h, the stability of the tra cer appeared to be excellent in human serum at 37 degrees C and when c hallenged with DTPA. Tc-99m-labeled B2C114 demonstrated good and speci fic in vivo tumor targeting.